How Should We View the Results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?
Open Access
- 29 January 2008
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (3) , 670-673
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Prognostic false-positivity of the sentinel node in melanomaNature Clinical Practice Oncology, 2008
- Why perform sentinel-lymph-node biopsy in patients with melanoma?Nature Clinical Practice Oncology, 2008
- Sentinel-Node Biopsy in MelanomaNew England Journal of Medicine, 2007
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Sentinel Lymphadenectomy Does Not Increase the Incidence of In-Transit Metastases in Primary MelanomaJournal of Clinical Oncology, 2005
- The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph NodesJournal of Clinical Oncology, 2005
- Predictors and Natural History of In-Transit Melanoma After Sentinel LymphadenectomyAnnals of Surgical Oncology, 2005
- A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous MelanomaAnnals of Surgical Oncology, 2005
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998